MRI study of brain reveal mild cerebral atrophy and small vessel ischemic changes Grade I FAZEKA.
Reading File
Finding Sources
Finding Sources
Searching PubMed
Fazekas scale white matter hyperintensity small vessel disease
Finding Sources
Finding Sources
Reading File
Finding Sources
Searching the Web
Fazekas Grade 1 white matter hyperintensity clinical significance management 44 year old
Reading Web Page
Fazekas grade 1 white matter hyperintensity management treatment recommendations
Finding Sources
Here is a comprehensive explanation of this MRI brain report for Rakesh Garg, 44 years, Male:
MRI Brain Report — Plain Language Explanation
What Was Done
A multiplanar 3 Tesla MRI was performed using T1W, T2W, T2 FLAIR, DWI, and SWI sequences — a thorough, high-quality brain study.
Key Findings Explained
1. Mild Cerebral Atrophy
The brain shows mild volume loss (atrophy). Some degree of atrophy is a normal aging change, but it is unusual to see even mild atrophy at age 44. It suggests the brain is aging at a slightly accelerated pace. It is not dementia, and no acute brain damage is present.
2. Small Vessel Ischemic Changes — Fazekas Grade I
This is the most important finding. The report describes T2/FLAIR hyperintensities (bright spots on MRI) in the:
- Bilateral periventricular region (white matter surrounding the ventricles)
- Centrum semiovale (central white matter of the brain)
These are collectively graded as Fazekas Grade I, which is the mildest level on a 0–3 scale:
| Grade | Description |
|---|---|
| 0 | No lesions |
| 1 (this patient) | Punctate (small, dot-like) foci — mild |
| 2 | Early confluence (lesions beginning to merge) — moderate |
| 3 | Large confluent areas — severe |
These changes reflect cerebral small vessel disease (CSVD) — microscopic damage to tiny blood vessels in the brain's white matter, causing reduced blood supply and patches of injury. They are also historically called leukoaraiosis.
3. Other Normal Findings (Reassuring)
- No hemorrhage (bleeding)
- No stroke or infarction
- Normal basal ganglia, thalami, cerebellum, and brainstem
- Normal ventricular system, no midline shift
- Major arteries (carotids, basilar) appear normal
- Partial empty sella — a common incidental finding, usually benign
- Bilateral mastoid air cell signal — suggests mastoiditis (mild sinus/mastoid inflammation) — worth a clinical ENT review
Why Does a 44-Year-Old Have These Changes?
Fazekas Grade 1 changes are found in ~34% of people in their mid-40s, but their presence in a younger person strongly signals modifiable vascular risk factors that need urgent attention:
| Risk Factor | Action |
|---|---|
| Hypertension | Most common driver — target BP ≤ 120/80 mmHg |
| Diabetes / Pre-diabetes | Check HbA1c |
| Dyslipidemia | Check fasting lipid profile |
| Smoking | Cessation is critical |
| Obesity / Metabolic syndrome | Lifestyle modification |
| Sleep apnea | Often overlooked vascular contributor |
Clinical Significance
Fazekas Grade 1 changes are not immediately dangerous, but they carry important long-term implications if left unaddressed:
- Progression risk: Can advance to Grades 2–3 with uncontrolled vascular risk factors
- Cognitive risk: Even early WMH are associated with slowing in attention, executive function, and processing speed over time
- Stroke risk: CSVD increases susceptibility to both ischemic and hemorrhagic stroke
- Atrophy correlation: A 2025 study (Frontiers in Neurology) confirms WMH are linked to gray matter atrophy — both processes reinforce each other
Recommended Investigations
Based on the 2023 Australian Consensus Statement on incidentally found WMH:
- Blood pressure monitoring (24-hour ambulatory BP preferred)
- Fasting lipid panel
- HbA1c and fasting glucose
- Complete blood count, renal function, thyroid function
- Neurological / cognitive baseline assessment (MMSE or MoCA)
- ENT consultation for bilateral mastoiditis finding
Management Recommendations
| Intervention | Goal |
|---|---|
| Antihypertensives | BP target 120/80 mmHg — has modest but proven effect on slowing WMH progression |
| Statins | Lipid control, reduce cardiovascular risk |
| Lifestyle | Mediterranean diet, aerobic exercise ≥150 min/week, smoking cessation |
| No antiplatelet therapy (yet) | Not indicated for asymptomatic Grade 1 WMH in the absence of stroke |
| Follow-up MRI | In 2–3 years to monitor progression |
| Neurology referral | Advisable given the patient's young age |
Summary
This MRI shows early, mild vascular changes in the brain of a relatively young man. The findings are not an emergency and are partially reversible in progression with aggressive vascular risk factor control. The most important next steps are identifying and treating hypertension, diabetes, and dyslipidemia, alongside lifestyle optimization. Consultation with a neurologist and internist is strongly advised given the patient's age (44 years).
⚠️ Note for the treating physician (Dr. Anuj Sarda): The combination of mild cerebral atrophy + CSVD at age 44 warrants a thorough workup for secondary causes including vasculitis, antiphospholipid syndrome, CADASIL, or metabolic disorders, in addition to routine cardiovascular risk assessment.
This is a shared conversation. Sign in to Orris to start your own chat.